THALED CAPSULES Drug Use-results comparison Survey (Crow-Fukase (POEMS) syndrome)

THALED CAPSULES Drug Use-results comparison Survey (Crow-Fukase (POEMS) syndrome) - THALED CAPSULES Drug Use-results comparison Survey (Crow-Fukase (POEMS) syndrome)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043601

Enrollment

100

Registered

2021-03-15

Start date

2021-02-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crow-Fukase (POEMS) syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who visit the subject medical institution for POEMS syndrome when THALED CAPSULES was approved

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Safety (arrhythmia and risk factors for arrhythmia)	—

Countries

Japan

Contacts

Public ContactMasanao Nakatani

Fujimoto Pharmaceutical Corporation Department of Pharmacovigilance

pms@fujimoto-pharm.co.jp072-332-5151

Outcome results